Overview

Safety Study of Human Milk Oligosaccharides in Healthy Adults

Status:
Completed
Trial end date:
2017-02-13
Target enrollment:
Participant gender:
Summary
First-in-human phase 1 study conducted in healthy adult male and female volunteers to determine the safety and tolerability of increasing doses of PBCLN-003, which are concentrated human milk oligosaccharides (HMO).
Phase:
Phase 1
Details
Lead Sponsor:
Prolacta Bioscience